|
  
- 积分
- 635
- 威望
- 635
- 包包
- 192
|
本帖最后由 flydayzhu 于 2010-8-28 16:37 编辑 , X0 l. x' u$ R* d: P S
. h- u6 e6 ]. }: R- a
麻烦大家了，最好是能够提供杂志版的，看着相对舒服点，谢谢~: ]) J8 l& P" t" h
) O# \9 W0 U5 l, |9 z0 j2 l- h
1.Promotion of direct reprogramming by transformation-deficient Myc.& O3 [6 D- M; D# q- q4 G
Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.
7 O3 Q1 C# l5 Z+ w' P
% ^4 i2 l2 i( R. o( @" vCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp
% I/ n, [/ t- u9 N A/ Z8 Ghttp://www.ncbi.nlm.nih.gov/pubmed/20660764( J8 ` {/ F1 F" y. ?# }
5 f; C' Y8 X, B- @- {2 U& V
2.Stem Cells. 2010 Aug;28(8):1349-54.
6 I5 b9 F* |9 U i* B' iAberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.- U$ G: P3 Z+ c6 w6 y, F
Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.2 g3 I9 r% e% _% B$ P' [
4 L% `) t9 l) |: q* F! {
Departments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.6 O5 g4 W; g$ t$ n4 h. S$ g* e
http://www.ncbi.nlm.nih.gov/pubmed/205720150 y w3 v9 i; l- B! m& Z0 X1 J
* o; ]3 B8 O) T! z2 D. A3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.
1 p. v- g* N1 R4 t8 `Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.9 |2 n3 X4 t+ |+ E; d! J
Smith ZD, Nachman I, Regev A, Meissner A.- d$ ]) `7 | Q5 [- g
$ p; u) A3 Q' m# D( C( z# P/ dBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
! M* A, k" W$ {7 XComment in:
& Y" J4 v. M& O$ Z% h6 B2 g5 D: I0 J6 k- }: I0 z l2 \
Regen Med. 2010 Jul;5(4):501-3.7 S! A, ]" q6 E6 N; D0 H: G4 c
http://www.ncbi.nlm.nih.gov/pubmed/20436460
f& F' ?: _3 I f( i
. _: Y% m- w" L' d4.PLoS One. 2010 Mar 24;5(3):e9838.$ a3 i) t1 [' I2 B; T" o4 `
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.& W( z: c% x4 V5 @8 `2 B$ n
Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.! N+ C) ~2 s# o) E$ e" K( Q9 ?
1 M, [" A+ q( O$ VMolecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America.
, h* j+ [* ~3 q' W' h6 S& \+ K; Thttp://www.ncbi.nlm.nih.gov/pubmed/20352099
V9 I* G* H! q& s& {4 C
r2 c( a: ?1 H4 o5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.
6 N9 O$ R9 r& c" l8 z+ ^0 A: i/ W; iDirect reprogramming 101.
$ L! f: B: ~- `5 p& M: qTakahashi K.3 m; C* {& z; f
9 p( V* w& D4 F0 T5 zCenter for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp& O) S' f. x" N- C
http://www.ncbi.nlm.nih.gov/pubmed/20298260
2 F6 i5 `* c w+ Q" g' X o% E
5 q$ z( I' a" t/ ]6.Nature. 2009 Oct 1;461(7264):649-3.
6 e' }. l: w, G: [; KDirect reprogramming of human neural stem cells by OCT4.( k' U0 t' g1 s. M* Y1 B
Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.
" |3 S1 U8 d1 c }* X5 u7 h* ?) `1 i5 Z
Max Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany.* P! y8 i; Y, H* _; Y x' u
http://www.ncbi.nlm.nih.gov/pubmed/197180187 u3 T3 R" X9 _' y& N1 J3 A
6 x4 N) u1 `; x" j o1 E# b/ t$ K
7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.( w+ u6 t% }$ R+ s
Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.
. ?# k; r: e9 r# R/ g" W7 W* z+ UOkabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.+ L7 `. [$ P) q6 a
9 C" Y0 G8 a' O/ ~3 r; h% ]
Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
3 {) [; J" j# Q& S2 mhttp://www.ncbi.nlm.nih.gov/pubmed/19564635& @- R3 L0 v4 v' c( z" `! m8 O
; @) X% i+ J0 P
8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.
; F; e7 v% O2 E7 H: G: [" W- a7 Q/ aRole of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
& y1 ?% Y" }3 }! S" vChen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.
8 h9 z- L' m# o8 @! b) R, E; G M' ]* K2 l# D
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.; b' F# P3 Z. @( Q. ~) t4 b
http://www.ncbi.nlm.nih.gov/pubmed/19524692
+ M& G! s7 `: a5 A) x* b; \5 f$ t! p+ }
9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31.( K: p* `. ~6 f5 |3 @
Upping the ante: recent advances in direct reprogramming." e4 o' a1 Y* Z" M& o
Müller LU, Daley GQ, Williams DA.
: j3 l g; f1 e, d, S
5 k1 {$ W" a1 \/ \5 D0 W- ADepartment of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.7 s1 c: f' b. P
Comment in:8 ?# E' W) P3 K% v) i
& b$ C9 u5 }& p8 G/ a( oMol Ther. 2009 Jun;17(6):929-30.
! @$ ^0 K6 f7 q2 Uhttp://www.ncbi.nlm.nih.gov/pubmed/19337233
! O: P1 A; r c3 ]- l7 ]3 y; H$ {) |$ b# k6 T* u
10.Cell Stem Cell. 2008 Sep 11;3(3):346-53.
2 l3 Q8 f( ` D3 fA drug-inducible system for direct reprogramming of human somatic cells to pluripotency.
1 p3 k+ K# k# WHockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.
1 W/ J7 j- d2 L/ D: ?" Y8 \! j" {9 l$ s( u, `# t, J) \
The Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.6 q3 |, [! l! A$ U/ s, X% ]
http://www.ncbi.nlm.nih.gov/pubmed/18786421* W; j+ Z& G1 l
5 t& k8 D, V0 @3 p11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.' {3 V! Y3 b2 o3 v. s5 i7 U( S% f: M
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.0 m3 A, ?! B8 @3 W0 M1 R
Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R.
% v0 Y" B; [: v" ^" }- N$ X
2 [4 |1 G( W2 ^* I* aWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA. b6 z. |* v' ]- f
http://www.ncbi.nlm.nih.gov/pubmed/18594521
% ^! V8 j) w( a5 W* a; W' i' \2 w$ X, m s& I6 A
12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.
0 ]- w, J, e& @3 MDissecting direct reprogramming through integrative genomic analysis.. O( q* T7 @( R" P
Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.
) t8 I, y- |$ q$ Y; B1 P0 C
8 S' c0 F, _* `Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.* O* y3 y2 w& x1 p; y# A" ^
http://www.ncbi.nlm.nih.gov/pubmed/18509334- z8 e8 f* C1 }6 R! o$ l
6 E% I: `( P9 Z
13.Cell. 2008 Apr 18;133(2):250-64.5 ?# j+ u8 Z3 ~; a! @; G" v5 W5 M
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
" e0 n. k: _& f' i: C& w4 JHanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.
5 ^, r, S, w' b0 P, h, H$ `% I' e/ v& L3 L' k* y9 U8 x& b+ q
The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.0 Q" B7 {1 J/ l, _
http://www.ncbi.nlm.nih.gov/pubmed/18423197( w4 J1 y5 G/ @: t+ f. T* R
" A$ v) w. ?( S4 A# Z' ^14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.$ J9 U/ y8 |1 |7 N, S! p) F
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
% |) m* t6 b" H$ k4 \Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.5 d8 i7 v! K' M% \* E1 C
& E' I7 O9 I; Q0 Y% d/ uWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.1 m2 h2 M! e$ W/ B; A' `
http://www.ncbi.nlm.nih.gov/pubmed/18371436
1 e/ \4 W; T' v9 {5 x$ `' Z2 X4 Z
0 W( h7 t8 d6 J2 `+ i, K m15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.
# T6 Q- o4 a" d' E7 S$ }c-Myc is dispensable for direct reprogramming of mouse fibroblasts., z% H1 w" I7 h# |% r8 w# O
Wernig M, Meissner A, Cassady JP, Jaenisch R.
0 u+ e5 i% v# a( chttp://www.ncbi.nlm.nih.gov/pubmed/18371415
% t8 f. F8 X) v% N j
+ Z2 J- l3 @- w# C0 R/ x16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.
& R) _! z; ^* mThe first direct reprogramming of adult human fibroblasts.
! c- B1 \8 G$ ?7 s `2 {Wilmut I.0 M" p0 l' i5 p! m9 f
% L, j) P* c( l- e9 o$ S+ i* xScottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk- N5 _ k% n/ D! B' ^0 ]
http://www.ncbi.nlm.nih.gov/pubmed/18371396
; ^% A7 T- y8 j4 E; Y$ \9 _% v. K. [9 _/ R7 \6 X8 P
17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.7 A9 M, w: s" N$ l) e9 Y
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
0 m/ J0 G' x/ r% a4 EMeissner A, Wernig M, Jaenisch R.! h8 I" u& d7 t# Y- y6 i
+ G1 R" }7 R p6 F7 [) tWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.
4 E- p6 s2 U1 Ahttp://www.ncbi.nlm.nih.gov/pubmed/17724450 |
|
发表于 2010-8-28 16:35
发表于 2010-8-28 17:00
